Starving the malaria parasite:: Inhibitors active against the aspartic proteases plasmepsins I, II, and IV

被引:76
作者
Hof, F
Schütz, A
Fäh, C
Meyer, S
Bur, D
Liu, J
Goldberg, DE
Diederich, F
机构
[1] ETH, Organ Chem Lab, HCI, CH-8093 Zurich, Switzerland
[2] Univ Victoria, Dept Chem, STN CSC, Victoria, BC V8W 3V6, Canada
[3] Actel Pharmaceut, CH-4123 Allschwil, Switzerland
[4] Washington Univ, Howard Hughes Med Inst, Dept Med, St Louis, MO 63110 USA
[5] Washington Univ, Howard Hughes Med Inst, Dept Mol Microbiol, St Louis, MO 63110 USA
关键词
aspartic proteases; drug design; inhibitors; malaria; medicinal chemistry;
D O I
10.1002/anie.200504119
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Clamping down: A new class of aspartic protease inhibitors that target the malarial protease family Plasmepsin are reported. These ligands utilize a novel "diamine clamp" to engage the catalytic dyad. They are potent inhibitors of plasmepsins I, II, and IV, while retaining good selectivity against the closely related human cathepsins D and E. (Chemical Equation Presented) .© 2006 Wiley-VCH Verlag GmbH & Co. KGaA.
引用
收藏
页码:2138 / 2141
页数:4
相关论文
共 22 条
[1]   Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparum [J].
Asojo, OA ;
Gulnik, SV ;
Afonina, E ;
Yu, B ;
Ellman, JA ;
Haque, TS ;
Silva, AM .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 327 (01) :173-181
[2]   Structural insights into the activation of P-vivax plasmepsin [J].
Bernstein, NK ;
Cherney, MM ;
Yowell, CA ;
Dame, JB ;
James, MNG .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 329 (03) :505-524
[3]   Inhibitors of the Plasmodium falciparum parasite aspartic protease plasmepsin II as potential antimalarial agents [J].
Boss, C ;
Richard-Bildstein, S ;
Weller, T ;
Fischli, W ;
Meyer, S ;
Binkert, C .
CURRENT MEDICINAL CHEMISTRY, 2003, 10 (11) :883-907
[4]   Development of a new class of inhibitors for the malarial aspartic protease plasmepsin II based on a central 7-azabicyclo[2.2.1]heptane scaffold [J].
Carcache, DA ;
Hörtner, SR ;
Seiler, P ;
Diederich, F ;
Dorn, A ;
Märki, HP ;
Binkert, C ;
Bur, D .
HELVETICA CHIMICA ACTA, 2003, 86 (06) :2173-2191
[5]   A new class of inhibitors for the malarial aspartic protease plasmepsin II based on a central 11-azatricyclo[6.2.1.02,7]undeca-2,4,6-triene scaffold [J].
Carcache, DA ;
Hörtner, SR ;
Bertogg, A ;
Diederich, F ;
Dorn, A ;
Märki, HP ;
Binkert, C ;
Bur, D .
HELVETICA CHIMICA ACTA, 2003, 86 (06) :2192-2209
[6]  
Carcache DA, 2002, CHEMBIOCHEM, V3, P1137, DOI 10.1002/1439-7633(20021104)3:11<1137::AID-CBIC1137>3.0.CO
[7]  
2-A
[8]   MAB, A GENERALLY APPLICABLE MOLECULAR-FORCE FIELD FOR STRUCTURE MODELING IN MEDICINAL CHEMISTRY [J].
GERBER, PR ;
MULLER, K .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1995, 9 (03) :251-268
[9]   ORDER AND SPECIFICITY OF THE PLASMODIUM-FALCIPARUM HEMOGLOBIN DEGRADATION PATHWAY [J].
GLUZMAN, IY ;
FRANCIS, SE ;
OKSMAN, A ;
SMITH, CE ;
DUFFIN, KL ;
GOLDBERG, DE .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (04) :1602-1608
[10]   Potent, low-molecular-weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II [J].
Haque, TS ;
Skillman, AG ;
Lee, CE ;
Habashita, H ;
Gluzman, IY ;
Ewing, TJA ;
Goldberg, DE ;
Kuntz, ID ;
Ellman, JA .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (08) :1428-1440